Zealand Pharma A/S (ZLDPF)
48.24
-2.27
(-4.49%)
USD |
OTCM |
Aug 24, 16:00
Zealand Pharma Debt to Equity Ratio : 0.0228 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0228 |
| March 31, 2026 | 0.0286 |
| December 31, 2025 | 0.0274 |
| September 30, 2025 | 0.0268 |
| June 30, 2025 | 0.0254 |
| March 31, 2025 | 0.0475 |
| December 31, 2024 | 0.0455 |
| September 30, 2024 | 0.0438 |
| June 30, 2024 | 0.0415 |
| March 31, 2024 | 0.1371 |
| December 31, 2023 | 0.0749 |
| September 30, 2023 | 0.0639 |
| June 30, 2023 | 0.0677 |
| March 31, 2023 | 0.7613 |
| December 31, 2022 | 0.6423 |
| September 30, 2022 | 1.353 |
| June 30, 2022 | 0.9613 |
| March 31, 2022 | 1.113 |
| December 31, 2021 | 0.8487 |
| September 30, 2021 | 0.1198 |
| June 30, 2021 | 0.1037 |
| March 31, 2021 | 0.0774 |
| December 31, 2020 | 0.1058 |
| September 30, 2020 | 0.084 |
| June 30, 2020 | 0.0761 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0833 |
| December 31, 2019 | 0.069 |
| September 30, 2019 | 0.0486 |
| June 30, 2019 | 0.0035 |
| March 31, 2019 | 0.0055 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.4536 |
| March 31, 2018 | 0.3177 |
| December 31, 2017 | 0.2637 |
| September 30, 2017 | 0.2221 |
| June 30, 2017 | 0.8046 |
| March 31, 2017 | 0.6391 |
| December 31, 2016 | 1.194 |
| September 30, 2016 | 1.434 |
| June 30, 2016 | 2.894 |
| March 31, 2016 | 1.194 |
| December 31, 2015 | 1.241 |
| September 30, 2015 | 2.090 |
| June 30, 2015 | 1.847 |
| March 31, 2015 | 1.476 |
| December 31, 2014 | 1.076 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Genmab A/S | 0.8852 |
| Ascendis Pharma A/S | 0.3133 |
| Bavarian Nordic A/S | 0.0099 |
| Evaxion AS | 0.7455 |
| Novo Nordisk A/S | 0.6333 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.023B |
| Total Liabilities (Quarterly) | 269.50M |
| Shareholders Equity (Quarterly) | 2.753B |
| Current Ratio | 13.98 |
| Net Debt Paydown Yield | -0.04% |